“Imaging is the key to the health of the future focused on prevention and regular monitoring”
Ángel Alberich-Bayarri, director and founder of QUIBIM, will participate for the second year running at the Longevity World Forum. His intervention, which will form part of the session on RDI in longevity, will reveal the applications and possibilities of artificial intelligence in this field.
Pedro Almaida: “As the circadian system ages, an organism’s ability to adjust its biological rhythms to environmental cycles is compromised”
Dr. Pedro Almaida has been researching the circadian system for years. His participation in the 2019 Longevity World Forum will give him the opportunity to explain its importance in terms of healthy ageing and to report on the latest discoveries in this field.
Carlos F. Sánchez Ferrer: “Drugs that are able to inhibit the actions of adipokines can have a beneficial effect on arteries and can even reverse vascular aging”
Professor Carlos F. Sánchez Ferrer will explain in #Longevity19 the new pharmacological targets as far as vascular ageing is concerned.
Kanteron Systems y el imparable sector de la e-health
La start up internacional Kanteron Systems especializada en e-health participará en la primera edición del Longevity World Forum.
Aubrey de Grey anuncia que la medicación para revertir el envejecimiento será una realidad en solo cinco años
El gerontólogo biomédico también vaticina que los tratamientos de longevidad serán accesibles para toda la sociedad. De Grey visitará España en noviembre para participar en la primera edición del Longevity World Forum en Valencia.